课题基金 / 基金详情

Cytogenetics and molecular genetics of malignant gliomas

Cytogenetics and molecular genetics of malignant gliomas
恶性胶质瘤的细胞遗传学和分子遗传学
批准号:
01480360
负责人:
INAZAWA Johji
金额:
$3.84万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1989
资助国家:
日本
项目状态:
已结题
起止时间:
1989 至 1990

项目摘要

项目成果

INAZAWA Johji的其他基金

相似基金

相关文献

中文摘要
翻译
人类最常见的中枢神经系统肿瘤来自大脑中的神经胶质细胞。多形性胶质母细胞瘤(GBM)是一种恶性程度最高的脑肿瘤,目前尚无法治愈。在这些肿瘤中,已有几种类型的遗传改变被报道,如基因扩增、染色体区域丢失和细胞遗传学异常。对20例原发于神经外胚层的人脑肿瘤进行了癌基因(erbB、Nmyc、c-myc或v-sis)的扩增检测,其中包括8例胶质瘤。在2个GBM中扩增了erbB,在另一个GBM中共扩增了N-myc和c-sis。此外,为了确定特定的染色体位点是否在GBM中丢失,我们使用针对人类染色体3、7、8.9.10.13和22的Wome多态DNA标记检测了5 GB&F中的杂合性丢失(LOH)。4个GBM在10号染色体上显示LOH,另一个在8号和22号染色体上同时显示LOH。。此外,对15例脑肿瘤(胶质瘤13例,畸胎瘤13例,神经母细胞瘤1例)进行了细胞遗传学分析。其中6例可分析恶性胶质瘤。其中3例CASCs涉及9号染色体,但涉及的每个断裂点并不常见。双重最小染色体(Dmins)和均一染色区(i-ISR)。在4例复发或恶性胶质瘤中检测到基因扩增的细胞遗传学标志。此外,I(17q)在恶性神经母细胞瘤中也被检测到。目前的结果表明ErbB扩增与胶质瘤的发生或侵袭性密切相关。同时也提示在10号染色体上存在一个与GBM发育有关的隐性基因。
英文摘要
The most common CNS neoplasms in humans are derived from glial cells in the brain. Glioblastoma multiform (GBM), the most malignant type of brain tumor, is at present incurable. In these tumors, several types of genetic alterations, such as gene amplification, loss of chromosomal regions and cytogenetic abnormalities have been reported. Amplification of oncogenes (erbB, Nmyc, c-myc or v-sis) were examined in 20 primary human brain tumors of neuroectodermal origin, including 8 GBMs. The erbB was amplified in 2 GBMS, and the N-myc and c-sis were coamplified in another GBM. Further, to determine whether specific chromosomal Ioci are lost in GBM, we examined loss of heterozygosity (LOH) in 5 GB&fs using Wome polymorphic DNA markers specific for human chromosomes 3, 7, 8.9.10.13 and 22. Four GBMs showed LOH on chromosome 10 and another showed simultancous LOH on chromosomes 8 and 22. . In addition, cytogenctic analysis was performed in 15 brain tumors (13 gliomas, I teratoma and I neurofibloma). Of them 6 malignant gliomas could be analyzed. Chromosomc 9 was involvcd in 3 cascs of them, although each breakpoint involved was not common. Doublc miinute chromosomes (dmins) and homogeneously staining region (I-ISR). which are cytogenetic hallmark of gene amplification, were detected in 4 recurrent or malignant gliomas. In addition i(17q)was detected in malignant neurofibloma.Present results indicate that erbb amplification is strongly associated with eumorgenesis or the aggressiveness of gliomas. and also suggest that a recessive gene involved in the development of GBM is present on chromosome 10.
期刊论文(41)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Inazawa, J., Fukunaga, R., Seto, Y., Nakagawa, H., Misawa, S., Abe, T., Nagata, S.: "Assignment of human granulocyte colony-stimulating factor receptor gene (CSF3R) to chromosome 1 at region p35-p34.3." Genomics. 10. 1075-1078 (1991)
Inazawa, J.、Fukunaga, R.、Seto, Y.、Nakakawa, H.、Misawa, S.、Abe, T.、Nagata, S.:“人粒细胞集落刺激因子受体基因 (CSF3R) 的分配
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
J.Inazawa,H.Nakagawa,S.Misawa,T.Abe,S.Minoshima,R.Fukuyama,M.Masatoshi,M.Hatanaka & N.Shimizu: "Assignment of human calpastatin gene (CAST) to chromosome 5 at region q14ー22" Cytogenet Cell Genet. 54. 156-158 (1990)
J. Inazawa、H. Nakakawa、S. Misawa、T. Abe、S. Minoshima、R. Fukuyama、M. Masatoshi、M. Hatanaka 和 N. Shimizu:“将人类钙蛋白酶抑制素基因 (CAST) 分配给 5 号染色体区域q14-22" 细胞遗传学细胞基因。54. 156-158 (1990)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 23 条
    Innovative development of DDS for microRNA therapeutics by an application of anti-PCSK9 antibody
    • 批准号:
      16K14630
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.41万
    • 财政年份:
      2016
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Chromothripsis-like pattern in cancer-cell genome after irradiation by a focused vertical micro-beam system, SPICE
    • 批准号:
      25640062
    • 项目类别:
      Grant-in-Aid for Challenging Exploratory Research
    • 资助金额:
      $2.58万
    • 财政年份:
      2013
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Development of diagnostic tools for personalized cancer medicine by genomic and epigenomic analyses
    • 批准号:
      22240090
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $32.12万
    • 财政年份:
      2010
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    Integrative genomics and epigenomics for personalized cancer medicine
    • 批准号:
      17015012
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $74.56万
    • 财政年份:
      2005
    • 负责人:
      INAZAWA Johji
    • 依托单位:
    国内基金
    海外基金
    RNA结合蛋白PABPC4在c-MYC诱导肝细胞癌发生中的作用及机制
    • 批准号:
      32100590
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      张鹏
    • 依托单位:
    溴结构域蛋白BRD4促进三阴性乳腺癌恶性生物学行为的机制研究
    • 批准号:
      32100584
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      卢琳琳
    • 依托单位:
    AGEs通过PLK1-CEP20诱发肝细胞中心体扩增进而诱发肿瘤发生的分子机制研究
    • 批准号:
      32100618
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      赵纪中
    • 依托单位:
    TRIM24通过调控NF-κB促进结直肠癌细胞增殖和存活的机制研究
    • 批准号:
      32100580
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      王雅
    • 依托单位: